Hostplus

"This investment reflects strong confidence in our technology, our team, and the impact Brainomix 360 Stroke and e-Lung can have on patient care. Stroke care depends on speed, while lung fibrosis care requires early identification and consistent clinical decision-making over time, underscoring the need for hospital technologies that support clinicians at the point of care. With this investment extension, we are well-positioned to enhance customer support across the US and Europe, accelerating the seamless integration of our technology into existing clinical workflows and expanding access to life-saving treatments."

"Aviation needs a solution, and the serious lever is SAF. The challenge is SAF cost, and that is exactly what we are addressing at OXCCU."

"We would like to thank all the investors that participated, including Parkwalk and Boehringer Ingelheim Venture Fund for their continued support, and welcome Hostplus, all of whom recognise the transformative impact that our technology can have on treatment for stroke and lung fibrosis patients. We will continue to harness our position and experience as a European market leader to achieve broad success in the US, helping improve patient care and access to life-changing therapies."

"From LEO satellite to terrestrial 5G deployments, the challenges of how to maximize the performance of the network, and in particular efficient use of energy and radio spectrum, are universal. Over the past few years, AccelerComm has continually demonstrated its position at the forefront of this technology, working with mobile operators, telecoms equipment vendors and the satellite industry to help supercharge communications. We’re thrilled to receive this backing from a range of industry-leading investors combined with the continued backing ongoing support of our existing shareholders and look forward to the company’s continued rapid growth and innovative development."